SNDX insider trading
Open-market stock trades by Syndax Pharmaceuticals (SNDX) executives and directors: who bought or sold, how many shares, at what price and when.
SNDX insider trades
| Date | Insider | Role | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 29, 2026 | Podlesak Dennis | director | Sell | 8,000 | $14.21 | $113.72K |
| Jul 8, 2026 | Metzger Michael A | Chief Executive Officer | Sell | 32,375 | $24.24 | $784.78K |
| Jun 11, 2026 | Botwood Nicholas A.J. | Head of R&D, CMO | Sell | 34,280 | $18.00 | $617.04K |
| Jun 12, 2026 | Botwood Nicholas A.J. | Head of R&D, CMO | Sell | 31,235 | $18.14 | $566.60K |
| Jun 1, 2026 | Goldan Keith A. | Chief Financial Officer | Sell | 1,177 | $18.99 | $22.35K |
| Jun 1, 2026 | Metzger Michael A | Chief Executive Officer | Sell | 6,847 | $18.99 | $130.02K |
| Feb 9, 2026 | Metzger Michael A | Chief Executive Officer | Sell | 17,159 | $21.03 | $360.82K |
| Feb 9, 2026 | Goldan Keith A. | Chief Financial Officer | Sell | 3,410 | $21.03 | $71.71K |
| Feb 6, 2026 | Metzger Michael A | Chief Executive Officer | Sell | 7,412 | $20.62 | $152.84K |
| Feb 6, 2026 | Goldan Keith A. | Chief Financial Officer | Sell | 2,082 | $20.62 | $42.93K |
| Sep 8, 2025 | Metzger Michael A | Chief Executive Officer | Sell | 157,307 | $16.41 | $2.58M |
| Aug 14, 2025 | Podlesak Dennis | director | Sell | 19,200 | $14.19 | $272.52K |
| Aug 15, 2025 | Podlesak Dennis | director | Sell | 19,200 | $15.54 | $298.41K |
| Aug 18, 2025 | Podlesak Dennis | director | Sell | 19,200 | $15.84 | $304.17K |
| Jul 16, 2025 | Goldan Keith A. | Chief Financial Officer | Sell | 1,296 | $9.29 | $12.03K |
| Jul 16, 2025 | Metzger Michael A | Chief Executive Officer | Sell | 7,534 | $9.29 | $69.95K |
| May 19, 2025 | Goldan Keith A. | Chief Financial Officer | Buy | 3,000 | – | $0.00 |
| May 16, 2025 | Botwood Nicholas A.J. | Head of R&D, CMO | Buy | 11,765 | $8.99 | $105.83K |
| May 19, 2025 | Huber Martin H. Jr. | director | Buy | 5,000 | $8.99 | $44.95K |
| May 19, 2025 | Katkin Keith | director | Buy | 10,000 | $9.11 | $91.12K |
| Mar 4, 2025 | Metzger Michael A | Chief Executive Officer | Sell | 7,814 | $15.05 | $117.56K |
| Feb 10, 2025 | Goldan Keith A. | Chief Financial Officer | Sell | 3,777 | $15.50 | $58.56K |
| Feb 10, 2025 | Metzger Michael A | Chief Executive Officer | Sell | 13,288 | $15.50 | $206.02K |
| Feb 10, 2025 | Gallagher Neil | President, Head of R&D | Sell | 4,618 | $15.50 | $71.60K |
| Jun 14, 2024 | Goldan Keith A. | Chief Financial Officer | Buy | 1,250 | $20.03 | $25.04K |
| Aug 9, 2023 | Morrison Briggs | director | Sell | 52,855 | $18.27 | $965.40K |
- SNDX insiders bought $266.93K and sold $7.82M in open-market trades over their last 26 filings.
Updated 2026-11-03 02:03 UTC